In total, 132 VA hospitals reported 2023 data on timely and effective care to CMS, of which statin medication is a reported measure. Data from 62 hospitals was not available for statin use at discharge because the hospitals did not have enough patients who met the reporting criteria, the hospitals’ results were included in a parent hospital’s data or the hospitals failed to report on the measure.
Statin medication is considered first-line therapy for patients who present with atherosclerotic cardiovascular disease, meaning hospitals that report a higher percentage of patients discharged on statin medication performed better on this measure.
Here are the VA hospitals who reported the highest rates of discharging patients with statin medication in 2023:
- Bronx VA Medical Center (New York City): 100%
- Columbia South Carolina VA Medical Center: 100%
- Fresno (Calif.) VA Medical Center—VA Central California Healthcare System: 100%
- Miami VA Medical Center: 100%
- St. Louis John Cochran VA Medical Center: 100%
- Syracuse (N.Y.) VA Medical Center: 100%
- VA Long Beach (Calif.) Healthcare System: 100%
- VA Pittsburgh Healthcare System – University Drive Campus: 100%
- VA Salt Lake City Healthcare—George E. Wahlen VA Medical Center: 100%
- San Antonio VA Medical Center—VA South Texas Healthcare System: 99%
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
